SCHEMBL6907013

SCHEMBL6907013

OCC1CN(c2ccccc2)CCN1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 8/20 0.60
HTR3E A5X5Y0 1/20 0.52
HTR3B O95264 1/20 0.52
HTR3A P46098 1/20 0.52
HTR3D Q70Z44 1/20 0.52
HTR3C Q8WXA8 1/20 0.52
SIGMAR1 Q99720 1/20 0.52
REN P00797 1/20 0.44
HTR1A P08908 1/20 0.43
HTR1D P28221 1/20 0.43
HTR2A P28223 1/20 0.43
HRH1 P35367 1/20 0.43
ADRA1B P35368 1/20 0.43
KCNH2 Q12809 1/20 0.43
SCN9A Q15858 1/20 0.43
NOTUM Q6P988 1/20 0.42
KHK P50053 2/20 0.41
USP2 O75604 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6907009 1.00 ADRB1 (0.60) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL9337575 0.87 ADRB1 (0.58) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL24028130 0.85 ADRB1 (0.46) ADRB1SCN9AADRA2AADRA2BADRA2C
SCHEMBL28437605 0.84 CHRNB2 (0.56) ADRB1
SCHEMBL38662353 0.84 ADRB2 (0.54) ADRB1SCN9AALDH1A1TSHRUSP25
SCHEMBL21876742 0.84 LTA4H (0.46) ADRB1SCN9AADRA2AADRA2BADRA2C
SCHEMBL16178593 0.84 ADRB1 (0.54) ADRB1HTR1AHTR1DKCNH2SCN9A
SCHEMBL21876740 0.84 LTA4H (0.46) ADRB1SCN9AADRA2AADRA2BADRA2C
SCHEMBL29104008 0.84 ADRB1 (0.45) ADRB1SCN9AUSP25USP28
SCHEMBL29104004 0.84 ADRB1 (0.45) ADRB1SCN9AUSP25USP28

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825200-B1 TREATING, PROLONGING, OR EXTENDING THE ONSET OF ORGAN REJECTION IN A HUMAN DURING OR AFTER ORGAN TRANSPLANTATION IN A HUMAN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
EP-1226159-A1 SUBSTITUTED DIPEPTIDES HAVING NOS INHIBITING ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-31 EP disclosed
WO-2001032690-A1 SUBSTITUTED DIPEPTIDES HAVING NOS INHIBITING ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-10 WO disclosed